Channel Therapeutics Corporation
Channel Therapeutics Corporation (CHRO) Stock Ownership
Institutional vs insider vs public ownership from 13F and float data — top holders, activity, and insider trades below.
SEC 13F · FMP · CHRO · as of Jun 30, 2025
Ownership Breakdown
5
Institutional Holders
▼ 4 vs Q1
$187,297
Total Inst. Value
▼ $658,878 vs Q1
6.60M
Shares Outstanding
freeFloat 38.83%
147,903
13F Shares Held
▼ 447,996 vs Q1
Institutional ownership = 13F shares ÷ total outstanding. Insider % = 100 − free float. Public % = free float − institution %. Data: FMP /symbol-positions-summary + /shares-float + SEC EDGAR.
Top Institutional Holders
CHRO largest shareholders · institutional ownership
Q2 2025 · SEC 13F
Showing top 10 holders
| Holder | Shares | % Owned | Weight | Value | Reported | Change |
|---|---|---|---|---|---|---|
MILLENNIUM MANAGEMENT LLC services-prepackaged software | 136.7K | 22.31% | 22.31% | $172.26M | Aug 14, 2025 | NEW |
GEODE CAPITAL MANAGEMENT, LLC services-prepackaged software | 10.4K | 1.70% | 1.70% | $14.09M | Aug 8, 2025 | ▲ 365 |
UBS GROUP AG services-prepackaged software | 652 | 0.11% | 0.11% | $822,000 | Aug 14, 2025 | ▼ 343 |
TOWER RESEARCH CAPITAL LLC (TRC) services-prepackaged software | 85 | 0.01% | 0.01% | $107,000 | Aug 15, 2025 | ▼ 2.5K |
BANK OF AMERICA CORP /DE/ services-prepackaged software | 19 | 0.00% | 0.00% | $24,000 | Aug 14, 2025 | ▲ 7 |
IKARIAN CAPITAL, LLC services-prepackaged software | 0 | 0.00% | 0.00% | $0 | Aug 14, 2025 | EXIT |
BARCLAYS PLC services-prepackaged software | 0 | 0.00% | 0.00% | $0 | Feb 27, 2026 | EXIT |
BOOTHBAY FUND MANAGEMENT, LLC services-prepackaged software | 0 | 0.00% | 0.00% | $0 | Aug 14, 2025 | EXIT |
TRADEWINDS CAPITAL MANAGEMENT, LLC services-prepackaged software | 0 | 0.00% | 0.00% | $0 | Jul 29, 2025 | EXIT |
WEALTH ENHANCEMENT ADVISORY SERVICES, LLC services-prepackaged software | 0 | 0.00% | 0.00% | $0 | Jul 10, 2025 | EXIT |
Data from SEC Form 13F filings. Ownership bar normalised to largest holder. Change flags: isNew / isSoldOut / changeInSharesNumber (FMP extract-analytics/holder).
Institutional Activity
Q2 2025 vs prior quarter
Q2 2025
2
Increased
+372 shares1
New Positions
first time holders2
Decreased
−2.8K shares5
Sold Out
fully exitedNet shares change (top 50)
2.5K
+372 / −2.8K
Net new holders
-4
1 new / 5 exited
Based on top 50 institutional holders by position size. Fields: isNew, isSoldOut, changeInSharesNumber (FMP extract-analytics/holder, limit=50).
Insider Buying vs Selling
CHRO insider trading · insider activity
Source: SEC Form 4
Insiders have been net buyers of shares recently. Selling may be driven by pre-scheduled Rule 10b5-1 plans rather than negative sentiment.
3
Buy transactions
0
Sell transactions
0.00
Buy/Sell ratio
$0M
Total disposed
Recent Insider Transactions
Showing 10 most recent · Common Stock only
| Name · Role | Date | Type | Shares | Price | Value | After Trans. | Filing |
|---|---|---|---|---|---|---|---|
Simmons Chia-Lin director | Apr 11, 2025 | Award | 25,000 | $1.35 | $33.8K | 130.0K | Form 4 ↗ |
Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Apr 11, 2025 | Award | 53,988 | $1.35 | $72.9K | 430.7K | Form 4 ↗ |
Davis Todd C director | Nov 13, 2024 | Award | 49,605 | $0.64 | $31.7K | 263.3K | Form 4 ↗ |
Malamut Richard director | Nov 13, 2024 | Award | 24,533 | $0.64 | $15.7K | 116.1K | Form 4 ↗ |
Friedberg Ezra M director | Nov 13, 2024 | Award | 24,533 | $0.64 | $15.7K | 634.8K | Form 4 ↗ |
Malamut Richard director | Sep 12, 2024 | Purchase | 10,400 | $0.94 | $9.8K | 91.6K | Form 4 ↗ |
Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Sep 13, 2024 | Purchase | 3,500 | $0.97 | $3.4K | 547.7K | Form 4 ↗ |
Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Sep 12, 2024 | Purchase | 1,700 | $0.97 | $1.6K | 544.2K | Form 4 ↗ |
Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Sep 11, 2024 | Purchase | 5,500 | $0.94 | $5.2K | 542.5K | Form 4 ↗ |
Francis Knuettel II CEO, Pres., CFO, Treas & Secty | Sep 10, 2024 | Purchase | 6,500 | $0.89 | $5.8K | 537.0K | Form 4 ↗ |
Source: /insider-trading/search (FMP stable). Buy/Sell direction: acquisitionOrDisposition A=Buy, D=Sell. RSU vesting (M-Exempt) excluded from sentiment bar. All data from SEC EDGAR public filings.
About institutional & insider ownership
Channel Therapeutics Corporation (CHRO) is primarily owned by institutional investors, who hold approximately 2.2% of total shares outstanding. Company insiders own approximately 61.17%, while retail and public investors account for the remaining 36.59%.
The largest institutional shareholder of Channel Therapeutics Corporation is MILLENNIUM MANAGEMENT LLC, holding approximately 136,712 shares — equal to 22.31% of outstanding shares — as of June 30, 2025.
A total of 5 institutional investors currently hold CHRO stock, with a combined institutional value of approximately $187,297 as of the most recent 13F filing period.
Frequently asked questions
CHRO ownershipChannel Therapeutics Corporation (CHRO) is primarily owned by institutional investors, who hold approximately 2.2% of shares. The largest shareholder is MILLENNIUM MANAGEMENT LLC with a 22.31% stake. Company insiders hold 61.17%. Data sourced from SEC Form 13F as of June 30, 2025.